Trupanion (TRUP) – Research Analysts’ Weekly Ratings Updates

Share on StockTwits

Trupanion (NASDAQ: TRUP) recently received a number of ratings updates from brokerages and research firms:

  • 6/18/2019 – Trupanion was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.
  • 6/14/2019 – Trupanion was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 6/8/2019 – Trupanion was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 5/31/2019 – Trupanion was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 5/23/2019 – Trupanion was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 5/23/2019 – Trupanion is now covered by analysts at Guggenheim. They set a “buy” rating and a $35.00 price target on the stock.
  • 5/16/2019 – Trupanion was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 5/14/2019 – Trupanion is now covered by analysts at Northland Securities. They set a “buy” rating and a $40.00 price target on the stock. They wrote, “We are assuming coverage of Outperform rating and a lower $40 price target. We believe that TRUP is successfully redefining the pet insurance industry and believe its severely under-penetrated TAM offers attractive long-term growth potential. We expect the company’s highly predictable subscription model with strong retention rates to continue to drive strong operating metrics and improving profitability over time. TRUP’s strong Q1:19 results featuring 15.4% subscription pets enrolled growth, ~5% monthly ARPP growth, 98.6% average monthly retention and improving FCF (+$3.1M, up ~184% YoY), we have continued conviction in the company’s ability to drive category growth and market penetration, while also improving upon its operating scale and metrics going forward.””
  • 5/9/2019 – Trupanion was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
  • 5/9/2019 – Trupanion was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating.
  • 4/25/2019 – Trupanion was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

Shares of TRUP stock traded up $1.71 on Wednesday, reaching $35.69. 168,933 shares of the company’s stock were exchanged, compared to its average volume of 257,592. Trupanion Inc has a 52 week low of $22.38 and a 52 week high of $46.70. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.85 and a current ratio of 1.85. The firm has a market capitalization of $1.23 billion, a P/E ratio of -1,189.67 and a beta of 1.21.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. The business had revenue of $86.98 million for the quarter, compared to the consensus estimate of $85.87 million. During the same period in the prior year, the business posted ($0.05) earnings per share. Trupanion’s revenue was up 24.7% on a year-over-year basis. As a group, sell-side analysts forecast that Trupanion Inc will post -0.07 EPS for the current year.

In other Trupanion news, insider Asher Bearman sold 10,300 shares of Trupanion stock in a transaction on Friday, March 29th. The stock was sold at an average price of $32.58, for a total transaction of $335,574.00. Following the completion of the sale, the insider now directly owns 8,191 shares of the company’s stock, valued at approximately $266,862.78. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Murray B. Low sold 10,000 shares of Trupanion stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $31.76, for a total value of $317,600.00. The disclosure for this sale can be found here. Insiders have sold a total of 82,403 shares of company stock valued at $2,638,473 over the last three months. 13.61% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the business. Clearbridge Investments LLC raised its position in shares of Trupanion by 38.6% in the 1st quarter. Clearbridge Investments LLC now owns 1,220,505 shares of the financial services provider’s stock worth $39,959,000 after acquiring an additional 339,812 shares in the last quarter. Millennium Management LLC grew its stake in Trupanion by 1,006.9% during the 4th quarter. Millennium Management LLC now owns 284,032 shares of the financial services provider’s stock worth $7,231,000 after buying an additional 258,372 shares during the last quarter. Nine Ten Capital Management LLC grew its stake in Trupanion by 8.1% during the 4th quarter. Nine Ten Capital Management LLC now owns 3,019,914 shares of the financial services provider’s stock worth $76,887,000 after buying an additional 227,423 shares during the last quarter. Gilder Gagnon Howe & Co. LLC purchased a new position in Trupanion during the 1st quarter worth $5,702,000. Finally, Phoenician Capital LLC purchased a new position in Trupanion during the 4th quarter worth $3,355,000. 97.80% of the stock is owned by institutional investors and hedge funds.

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Recommended Story: What is the Current Ratio?

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MKM Partners Lowers ADTRAN  Price Target to $17.00
MKM Partners Lowers ADTRAN Price Target to $17.00
Apple  PT Raised to $180.00 at Nomura
Apple PT Raised to $180.00 at Nomura
Advaxis  Lowered to “Hold” at ValuEngine
Advaxis Lowered to “Hold” at ValuEngine
Zacks Investment Research Upgrades Atlas Air Worldwide  to “Hold”
Zacks Investment Research Upgrades Atlas Air Worldwide to “Hold”
Apple  Raised to “Outperform” at Raymond James
Apple Raised to “Outperform” at Raymond James
Zacks Investment Research Lowers Agilysys  to Hold
Zacks Investment Research Lowers Agilysys to Hold


© 2006-2019 Ticker Report